|Hiroaki Shimokawa, MD, PhD.
The 9th International Conference on the Biology, Chemistry, and Therapeutic Applications of Nitric Oxide
Professor and Chairman, Department of Cardiovascular Medicine, Tohoku University
Graduate School of Medicine
Greetings from the President of the 9th International Conference on the Biology,
Chemistry, and Therapeutic Applications of Nitric Oxide
The Nitric Oxide Society of Japan was inaugurated by 20 researchers in May 2000 in response to a series of moves aimed at establishing NO societies in many parts of the world after the Nitric Oxide Society was founded in the United States in 1996 on the back of NO studies’ gaining momentum on a global scale. The scientific meeting has been held annually since 2001 (please refer to “The Purport of Establishment” and “The Scientific Meeting” on the society’s website).
The International Conference on the Biology, Chemistry, and Therapeutic Applications of Nitric Oxide has been held every two years in different parts of the world since 2000. In Japan, the third conference was organized by Dr. Naoyuki Taniguchi in Nara in 2004 and the 6th conference by Dr. Takaaki Akaike in Kyoto in 2010.
The year 2016 will mark the 30th anniversary of the identification of NO as an major endothelium-derived relaxing factor (EDRF) by the research groups of Dr. Furchgott and Dr. Ignarro. The importance of NO has been brought to light by immense advances in NO research. In 1998, three researchers, Dr. Furchgott, Dr. Ignarro, and Dr. Murrad, who demonstrated that cGMP is involved in the vasorelaxation mechanism of NO, were awarded the Nobel Prize in Physiology or Medicine.
NO research has become even more active on a global scale after the Nobel Prize was awarded to the three researchers in 1998. Reports of new findings in both basic and clinical research have appeared one after another. Specifically, in addition to the vasorelaxant and anti-arteriosclerotic effects of NO, it has become increasingly clear that NO plays a critical role in the functional maintenance of most cells as a signal molecule.
It is a great honor for us to host the International Conference on the Biology, Chemistry, and Therapeutic Applications of Nitric Oxide here in Japan in the year marking the 30th anniversary of NO studies.
I sincerely hope that researchers from all over the world will get together to engage in active exchanges of the latest information in NO research, with the common goal of furthering research and development in this area.